In situ analysis of HER2 mRNA in gastric carcinoma: Comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry

Human Pathology

Volumn 44, Issue 4, 2013, Pages 487-494

  Kim, Min A ^a   Jung, Jung Eun ^a   Lee, Hee Eun ^a   Yang, Han Kwang ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Dual color silver in situ hybridization; Fluorescence in situ hybridization; HER2; RNA in situ hybridization; Stomach neoplasm

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SCORING SYSTEM; STOMACH CARCINOMA; TUMOR RECURRENCE;

ADENOCARCINOMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RNA, MESSENGER; RNA, NEOPLASM; SILVER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875230527     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.022     Document Type: Article

References (21)

1. F.E. Odicino, E. Bignotti, and E. Rossi HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization Int J Gynecol Cancer 18 2008 14 21
2. N. Miyahara, J. Shoda, and K. Ishige MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications Eur J Cancer 44 2008 1048 1056
3. J.D. Barros-Silva, D. Leitao, and L. Afonso Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients Br J Cancer 100 2009 487 493
4. C.A. Hudis Trastuzumab - mechanism of action and use in clinical practice N Engl J Med 357 2007 39 51
5. I. Smith, M. Procter, and R.D. Gelber 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Lancet 369 2007 29 36
6. D.J. Slamon, B. Leyland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
7. Y.J. Bang, E. Van Cutsem, and A. Feyereislova Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 2010 687 697
8. M.F. Press, R.S. Finn, and D. Cameron HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer Clin Cancer Res 14 2008 7861 7870
9. C. Larsson, I. Grundberg, O. Soderberg, and M. Nilsson In situ detection and genotyping of individual mRNA molecules Nat Methods 7 2010 395 397
10. O.C. Ukpo, J.J. Flanagan, X.J. Ma, Y. Luo, W.L. Thorstad, and J.S. Lewis Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma Am J Surg Pathol 35 2011 1343 1350
11. M.A. Kim, H.J. Lee, H.K. Yang, Y.J. Bang, and W.H. Kim Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma Histopathology 59 2011 822 831
12. M. Hofmann, O. Stoss, and D. Shi Assessment of a HER2 scoring system for gastric cancer: results from a validation study Histopathology 52 2008 797 805
13. Y.S. Park, H.S. Hwang, and H.J. Park Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Hum Pathol 43 2012 413 422
14. I. Vanden Bempt, V. Vanhentenrijk, M. Drijkoningen, I. Wlodarska, P. Vandenberghe, and C. De Wolf-Peeters Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas Histopathology 46 2005 431 441
15. J. Arribas, J. Baselga, K. Pedersen, and J.L. Parra-Palau p95HER2 and breast cancer Cancer Res 71 2011 1515 1519
16. R.R. Tubbs, J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, and T.M. Grogan Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message J Clin Oncol 19 2001 2714 2721
17. L. Bernet, M. Martinez Benaclocha, and C. Castera mRNA in situ hybridization (HistoSonda): a new diagnostic tool for HER2-status in breast cancer - a multicentric Spanish study Diagn Mol Pathol 21 2012 84 92
18. Z. Suo, K.U. Daehli, C.F. Lindboe, E. Borgen, A. Bassarova, and J.M. Nesland Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients Int J Surg Pathol 12 2004 311 318
19. M. Barberis, C. Pellegrini, M. Cannone, C. Arizzi, G. Coggi, and S. Bosari Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis Am J Clin Pathol 129 2008 563 570
20. M. Dietel, I.O. Ellis, and H. Hofler Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists Virchows Arch 451 2007 19 25
21. E. Garcia-Garcia, C. Gomez-Martin, and B. Angulo Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method Histopathology 59 2011 8 17